Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-12-02, Stock:PFE, The news for the past five days is as follows:
2019-11-22: NEWS1: US Indexes Higher Friday, but Down for the Week.NEWS2: Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow.NEWS3: Top Research Reports for Pfizer, Netflix & Dominion Energy.NEWS4: [video]Top 5 Stock Winners in the Dow Jones Industrial Average This Week.NEWS5: Pharma Stock Roundup: FDA Nod to NVS' & AZN's Drugs, BMY-CELG Merger Closes.NEWS6: BioMarin Files MAA to EMA for Gene Therapy of Hemophilia A.NEWS7: Amgen (AMGN) Completes Otezla Buyout, Raises 2019 Guidance.NEWS8: NewsBreak: Trump Looks to Let Florida, Others Import Prescription Drugs.
2019-11-25: NEWS1: The Zacks Analyst Blog Highlights: Pfizer, Netflix, Dominion, Costco and Charles Schwab.NEWS2: Pfizer Has 5 Drugs in Its Pipeline That Could Turn Its Stock Around.NEWS3: 3 Health Care ETFs Hitting New Highs.NEWS4: 5 Drugs in Pfizer’s Pipeline That Could Turn the Stock Around.NEWS5: The Chinese Vape Market Is Booming. But Heavy Regulation Is Coming..NEWS6: Here is the 22nd Most Popular Stock Among 752 Hedge Funds.NEWS7: Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050.
2019-11-26: NEWS1: Astellas Announces the Approval of XTANDI® (enzalutamide) by the China National Medical Products Administration (NMPA).
2019-11-27: NEWS1: Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050.NEWS2: Merck's Keytruda Gets Nod in China for Difficult Lung Cancer.NEWS3: FOCUS-Pfizer, Novartis lead $2 bln spending spree on gene therapy production.NEWS4: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS5: Pfizer, Novartis lead $2 billion spending spree on gene therapy production.NEWS6: Pfizer/Astellas Xtandi Gets Nod in China for Prostate Cancer.
2019-11-29: NEWS1: China Negotiates Bargain Prices With Big Pharma.NEWS2: Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates.

Answer: Decrease